跳至主要内容
临床试验/NL-OMON26217
NL-OMON26217招募中不适用

Safety and Tolerability of Nebulized Amoxicillin-Clavulanic Acid in Patients with COPD.

Medisch Spectrum TwenteP.O.Box 50.0007500 KA EnschedeThe Netherlands0 个研究点目标入组 8 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
8

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. A clinical diagnosis of stable COPD, as defined by GOLD criteria;
  • 2. Able to produce sputum;

排除标准

  • 1. Exacerbation or use of prednisolone or antibiotics 4 weeks related to an exacerbation prior to enrolment;
  • 2. Current pneumonia, defined as an acute respiratory tract illness associated with radiographic shadowing on a chest radiograph which was neither pre-existing nor of any other cause;

研究者

发起方
Medisch Spectrum TwenteP.O.Box 50.0007500 KA EnschedeThe Netherlands

相似试验